JP2006528597A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528597A5
JP2006528597A5 JP2006520673A JP2006520673A JP2006528597A5 JP 2006528597 A5 JP2006528597 A5 JP 2006528597A5 JP 2006520673 A JP2006520673 A JP 2006520673A JP 2006520673 A JP2006520673 A JP 2006520673A JP 2006528597 A5 JP2006528597 A5 JP 2006528597A5
Authority
JP
Japan
Prior art keywords
alkyl
carbocyclyl
heterocyclyl
alkenyl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006520673A
Other languages
English (en)
Japanese (ja)
Other versions
JP4939216B2 (ja
JP2006528597A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2004/000490 external-priority patent/WO2005009940A1/en
Publication of JP2006528597A publication Critical patent/JP2006528597A/ja
Publication of JP2006528597A5 publication Critical patent/JP2006528597A5/ja
Application granted granted Critical
Publication of JP4939216B2 publication Critical patent/JP4939216B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006520673A 2003-07-24 2004-07-09 新規アミノベンゾフェノン化合物 Expired - Fee Related JP4939216B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48948803P 2003-07-24 2003-07-24
US60/489,488 2003-07-24
PCT/DK2004/000490 WO2005009940A1 (en) 2003-07-24 2004-07-09 Novel aminobenzophenone compounds

Publications (3)

Publication Number Publication Date
JP2006528597A JP2006528597A (ja) 2006-12-21
JP2006528597A5 true JP2006528597A5 (https=) 2007-09-06
JP4939216B2 JP4939216B2 (ja) 2012-05-23

Family

ID=34102888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006520673A Expired - Fee Related JP4939216B2 (ja) 2003-07-24 2004-07-09 新規アミノベンゾフェノン化合物

Country Status (25)

Country Link
US (1) US7977387B2 (https=)
JP (1) JP4939216B2 (https=)
KR (1) KR101128275B1 (https=)
CN (1) CN1826310B (https=)
AR (1) AR045082A1 (https=)
AT (1) ATE469878T1 (https=)
AU (1) AU2004259264B2 (https=)
BR (1) BRPI0412893A (https=)
CA (1) CA2530302C (https=)
DE (1) DE602004027504D1 (https=)
DK (1) DK1658263T3 (https=)
ES (1) ES2346972T3 (https=)
HR (1) HRP20100418T1 (https=)
IL (1) IL172429A0 (https=)
IS (1) IS2761B (https=)
MX (1) MXPA06000708A (https=)
MY (1) MY142988A (https=)
NO (1) NO20060230L (https=)
NZ (1) NZ544178A (https=)
PT (1) PT1658263E (https=)
RU (1) RU2396250C2 (https=)
TW (1) TWI337075B (https=)
UA (1) UA85559C2 (https=)
WO (1) WO2005009940A1 (https=)
ZA (1) ZA200510137B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200700811B (en) 2004-08-06 2008-10-29 Otsuka Pharma Co Ltd Aromatic compound
ES2341473T3 (es) * 2004-12-13 2010-06-21 Leo Pharma A/S Compuestos de aminobenzofenona sustituida con triazol.
JP5154406B2 (ja) 2005-04-13 2013-02-27 アステックス、セラピューティックス、リミテッド 医薬化合物
BRPI0615948A2 (pt) * 2005-09-07 2011-05-31 Plexxikon Inc composto ativo de ppar, sua composição, seu kit e seu uso
CN101321529B (zh) 2005-12-05 2012-09-05 大塚制药株式会社 作为抗肿瘤剂的二芳基醚衍生物
TW200732296A (en) * 2005-12-15 2007-09-01 Astrazeneca Ab Novel compounds
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
KR100932093B1 (ko) * 2006-09-27 2009-12-16 주식회사종근당 미세소관 형성 저해제로서 유용한 벤조페논 유도체
UA95978C2 (ru) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073802A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
PT2272845E (pt) * 2008-03-26 2015-06-01 Chong Kun Dang Pharm Corp Derivados de benzofenona-tiazole úteis para inibir a formação de microtúbulos e método para produzir os mesmos
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
MX2010014066A (es) 2008-06-16 2011-06-01 Univ Tennessee Res Foundation Compuestos para el tratamiento del cancer.
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
AU2009289649B2 (en) 2008-09-03 2016-05-05 Biomarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
JP5732471B2 (ja) 2009-12-22 2015-06-10 レオ ファーマ アクティーゼルスカブ 溶媒混合物およびビタミンd誘導体から成る医薬品組成物または類似体
RU2555339C2 (ru) 2009-12-22 2015-07-10 Лео Фарма А/С Нанокристаллы кальципотриола моногидрита
US20120322776A1 (en) 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
JP5879273B2 (ja) 2010-03-01 2016-03-08 ジーティーエックス・インコーポレイテッド 癌を処置するための化合物
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US9540395B2 (en) 2011-02-28 2017-01-10 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
TW201329025A (zh) 2011-11-01 2013-07-16 Astex Therapeutics Ltd 醫藥化合物
KR101229365B1 (ko) * 2012-07-02 2013-02-18 대한민국 〔z〕­n­〔3­〔2,4­디플루오로페닐아미노〕­1­〔4­나이트로페닐〕­3­옥소프로프­1­엔­2­일〕­2­메톡시벤즈아마이드를 유효성분으로 함유하는 신경퇴행성 질환 예방 및 치료용 약학적 조성물
DK2970139T3 (en) 2013-03-15 2018-08-13 Biomarin Pharm Inc HDAC inhibitors
CN103926794B (zh) * 2014-04-29 2017-11-14 常州强力电子新材料股份有限公司 一种含有二苯甲酮衍生物光引发剂的光固化组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701453D0 (en) * 1997-01-24 1997-03-12 Leo Pharm Prod Ltd Aminobenzophenones
KR20020013961A (ko) * 1999-07-16 2002-02-21 룬딩 에른스트 신규한 아미노벤조페논
EP1210320B1 (en) * 1999-07-16 2004-09-29 Leo Pharma A/S Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
DE60014681T2 (de) 1999-07-16 2006-02-02 Leo Pharma A/S Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
US6555710B1 (en) 1999-07-16 2003-04-29 Leo Pharmaceutical Products Ltd A/S Lovens Kemiske Fabrik Produktionsaktieselskab Aminobenzophenones as inhibitors of IL-1 β and TNF-α
AU768512B2 (en) * 1999-07-16 2003-12-18 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha
ATE362912T1 (de) * 1999-12-06 2007-06-15 Leo Pharma As Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
JP2004501191A (ja) * 2000-06-28 2004-01-15 テバ ファーマシューティカル インダストリーズ リミティド カルベジロール
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
EP1423356A2 (en) * 2001-08-28 2004-06-02 Leo Pharma A/S Novel aminobenzoephenones

Similar Documents

Publication Publication Date Title
JP2006528597A5 (https=)
JP2008540554A5 (https=)
JP2024543976A5 (https=)
JP2017528467A5 (https=)
JP2009536620A5 (https=)
JP2009542595A5 (https=)
JP2013510123A5 (https=)
JP2017523169A5 (https=)
JP2010533160A5 (https=)
JP2014503525A5 (https=)
JP2013545785A5 (https=)
ATE259803T1 (de) 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung
JP2016506962A5 (https=)
JP2009534338A5 (https=)
JP2011057678A5 (https=)
NZ547615A (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
JP2004534774A5 (https=)
JP2009531376A5 (https=)
JP2015522650A5 (https=)
JP2008546770A5 (https=)
JP2010522709A5 (https=)
JP2005511547A5 (https=)
JP2018529690A5 (https=)
JP2010522711A5 (https=)
JP2019507745A5 (https=)